You are on page 1of 1


Publicly-Traded Company
NIRE 35.300.172.507
CNPJ/MF No. 61.486.650/0001-83

Diagnsticos da Amrica S.A. ("Company"), informs, in accordance with the Law No. 6.404, enacted
on December 15, 1976, as amended, combined with article 2nd of the Securities and Exchange
Commission of Brazil ("CVM") Instruction No. 358, enacted on January 3, 2002, as amended
("ICVM 361"), in addition to the information provided in the Materials Facts disclosed by the
Company on April 27, 2015, May 7, 2015, May 11, May 18, May 28, June 3 and June 5, 2015, to its
shareholders and to the market that on June 8, 2015, a general shareholders meeting was held, in
which Ita BBA S.A., a specialized company, was selected to prepare the appraisal report of the
economic and financial value of the common shares issued by the Company, pursuant to the article
8 of ICVM361, in connection with the voluntary tender offer to be held by Cromossomo
Participaes II S.A. for delisting the Company from the New Market ("Voluntary Tender Offer"),
pursuant to the article 12, item IX, and article 43 of the Company's bylaws.
The shareholders of the Company also approved delisting the Company from the New Market,
pursuant to the items VIII of the article 12, Chapter V of the Company's bylaws, Sections X and XI
of the New Market Regulation of BM&FBOVESPA and ICVM361, subject to the implementation of
the Voluntary Tender Offer and in accordance with its terms and conditions.
DASA will keep its shareholders and the market informed of any developments of the matters in
this material fact.
Barueri, June 8, 2015.

Paulo Bokel Catta-Preta

Chief Investors Relations Officer